Skip to content

Advertisement

BMC Cancer

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Effects of the lysosomal destabilizing drug siramesine on glioblastoma in vitro and in vivo

  • Stine S. Jensen1, 2,
  • Stine A. Petterson1, 2,
  • Bo Halle1, 2, 3,
  • Charlotte Aaberg-Jessen1, 2 and
  • Bjarne W. Kristensen1, 2Email author
BMC Cancer201717:178

https://doi.org/10.1186/s12885-017-3162-3

Received: 9 September 2016

Accepted: 1 March 2017

Published: 7 March 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
9 Sep 2016 Submitted Original manuscript
10 Oct 2016 Reviewed Reviewer Report - Ganesh Rao
2 Feb 2017 Author responded Author comments - Stine Jensen
Resubmission - Version 2
2 Feb 2017 Submitted Manuscript version 2
20 Feb 2017 Author responded Author comments - Stine Jensen
Resubmission - Version 3
20 Feb 2017 Submitted Manuscript version 3
Publishing
1 Mar 2017 Editorially accepted
7 Mar 2017 Article published 10.1186/s12885-017-3162-3

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Pathology, Odense University Hospital
(2)
Institute of Clinical Research, University of Southern Denmark
(3)
Department of Neurosurgery, Odense University Hospital

Advertisement